Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a development stage biotechnology company. The Company is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA), an alpha-synucleinopathy. Its proprietary target discovery engine... see more

NDAQ:PMN - Post Discussion

ProMIS Neurosciences Inc > Looking forward to 2023
View:
Post by Gbathat on Dec 22, 2022 5:46pm

Looking forward to 2023

Wishing all the longs a blessed and peaceful holiday season, and looking forward to a more prosperous 2023.

Thanks to those here who have shared due diligence. May your investments of time and treasure one day be rewarded.

Cheers.
Comment by eiementai on Dec 23, 2022 1:26am
This post has been removed in accordance with Community Policy
Comment by M101 on Dec 23, 2022 2:19pm
I won't be entirely suprised if we get a massive share price increase because the current grift can't last. I mean look at the attitude here compared to before the aducanumab fiasco https://endpts.com/icer-on-alzheimers-lecanemab-should-be-priced-lower-than-aduhelm/  Everyone knows it's now time to clear an obsolte inventory of brain bleeding drugs that were never going to ...more  
Comment by azzymaa on Dec 29, 2022 9:09pm
This post has been removed in accordance with Community Policy
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities